Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MEG3
   Synonyms MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1
   Region GRCh38_14:100779410-100861031    Sequence
   Ensembl ENSG00000214548
   RefSeq NR_002766
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name non-functioning pituitary adenoma
   ICD-0-3 C75.1  M8272/0
   Methods qPCR, Cell transfection, Western blot, Northern blot, Flow cytometry assay etc.
   Sample NFA tissues, cell line (PDFS)
   Expression Pattern differential expression
   Function Description

In this study, we introduced MEG3 expression into PDFS cells, derived from a human NFA, using both inducible and constitutively active expression systems. MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. In addition, inactivation of p53 completely abolished tumor suppression by MEG3, indicating that MEG3 tumor suppression is mediated by p53.

   Pubmed ID 26284494
   Year 2015
   Title Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.
   External Links
   Links for  MEG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  non-functioning pituitary adenoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.